AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32916308 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CRT) with pembrolizumab
Number of subjects: 40
Study 36430060 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention for dormitory environment and roommate behaviour (3 months)
Number of subjects: 364
Study 36430060 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 364
Study 34953042 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofarabine
Number of subjects: 0
Study 34953042 — intervention group
Group type: COMPARATOR
Intervention: Standard induction chemotherapy
Number of subjects: 0
Study 33036027 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac surgery in patients with pre‐ICH
Number of subjects: 363
Study 33036027 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative management in patients with pre‐ICH
Number of subjects: 363
Study 35513593 — intervention group
Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 22
Study 35513593 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene Citrate
Number of subjects: 22
Study 34328366 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy (ERC; using antiarrhythmic drugs or catheter ablation)
Number of subjects: 798
Study 34328366 — intervention group
Group type: COMPARATOR
Intervention: Usual care (allowing rhythm control therapy to improve symptoms)
Number of subjects: 798
Study 34328366 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy (ERC)
Number of subjects: 798
Study 36287306 — intervention group
Group type: EXPERIMENTAL
Intervention: Berdazimer gel, 10.3%, applied once daily for 12 weeks
Number of subjects: 891
Study 36287306 — intervention group
Group type: EXPERIMENTAL
Intervention: Berdazimer gel, 10.3%
Number of subjects: 891
Study 36287306 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 891
Study 33246896 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based virtual nursing intervention (experimental group, n = 37)
Number of subjects: 75
Study 33246896 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 38) invited to consult epilepsy-related websites
Number of subjects: 75
Study 33213406 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal nutrition education and child spacing interventions
Number of subjects: 422
Study 35246028 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin group (n=11)
Number of subjects: 28
Study 35246028 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT group (n=17)
Number of subjects: 28
Study 35246028 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Aspirin and DAPT)
Number of subjects: 28
Study 32165270 — intervention group
Group type: EXPERIMENTAL
Intervention: Food sensory imagery condition (imagining taste, smell, and texture of palatable foods)
Number of subjects: 171
Study 32165270 — intervention group
Group type: COMPARATOR
Intervention: Control condition (sensory imagery task for non-food-related activities)
Number of subjects: 171
Study 32165270 — intervention group
Group type: EXPERIMENTAL
Intervention: Food sensory imagery intervention
Number of subjects: 171
Study 35770120 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine therapy (0.050.5 μg∗kg‐1/min)
Number of subjects: 86
Study 35770120 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (115 μg/kg∗min dopamine)
Number of subjects: 86
Study 35770120 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine therapy
Number of subjects: 86
Study 32530836 — intervention group
Group type: EXPERIMENTAL
Intervention: Comic and video
Number of subjects: 57
Study 32530836 — intervention group
Group type: COMPARATOR
Intervention: Comic only
Number of subjects: 57
Study 34957632 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise in humid heat (40°C, 52% relative humidity)
Number of subjects: 13
Study 34957632 — intervention group
Group type: COMPARATOR
Intervention: Hot water immersion (TWI; 36.6°C, thermoneutral)
Number of subjects: 13
Study 34957632 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauna (55°C, 52% relative humidity)
Number of subjects: 13
Study 34957632 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stress in 40°C water
Number of subjects: 13
Study 33431380 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred e-health platform (Target-D)
Number of subjects: 1868
Study 33431380 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1868
Study 32795562 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task training (20 sessions, 1 hour each, twice a week)
Number of subjects: 40
Study 32795562 — intervention group
Group type: COMPARATOR
Intervention: Single-task training (20 sessions, 1 hour each, twice a week)
Number of subjects: 40
Study 35774272 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic and static shoulder joint brace
Number of subjects: 0
Study 35774272 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34670042 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg lanifibranor
Number of subjects: 247
Study 34670042 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg lanifibranor
Number of subjects: 247
Study 34670042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 32428341 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective messaging
Number of subjects: 116
Study 32428341 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental messaging
Number of subjects: 116
Study 32428341 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation messaging
Number of subjects: 116
Study 32428341 — intervention group
Group type: COMPARATOR
Intervention: Control (nutrition information)
Number of subjects: 116
Study 36472870 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving treatment (PST)
Number of subjects: 511
Study 36472870 — intervention group
Group type: COMPARATOR
Intervention: Health education (control)
Number of subjects: 511
Study 33627215 — intervention group
Group type: EXPERIMENTAL
Intervention: DPMAS
Number of subjects: 36
Study 33627215 — intervention group
Group type: COMPARATOR
Intervention: PE
Number of subjects: 36
Study 34328623 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 41
Study 34328623 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 35941584 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment for 24 weeks
Number of subjects: 129
Study 35941584 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride treatment for 24 weeks
Number of subjects: 129
Study 35941584 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment
Number of subjects: 129
Study 33236103 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-release hydrocortisone (DR-HC)
Number of subjects: 50
Study 33236103 — intervention group
Group type: COMPARATOR
Intervention: TID-hydrocortisone (TID-HC)
Number of subjects: 50
Study 33236103 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (DR-HC and TID-HC)
Number of subjects: 50
Study 32912140 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to WHO guidelines for antibiotic treatment
Number of subjects: 1564
Study 32912140 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger facility size
Number of subjects: 1564
Study 32912140 — intervention group
Group type: EXPERIMENTAL
Intervention: Inborn infants
Number of subjects: 1564
Study 32912140 — intervention group
Group type: EXPERIMENTAL
Intervention: Dis-advantaged caste families
Number of subjects: 1564
Study 32912140 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical presentation of lethargy or tachypnoea
Number of subjects: 1564
Study 32912140 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 1564
Study 34284771 — intervention group
Group type: EXPERIMENTAL
Intervention: Textbook study
Number of subjects: 67
Study 34284771 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face seminar
Number of subjects: 67
Study 34284771 — intervention group
Group type: EXPERIMENTAL
Intervention: Video tutorial via online platform
Number of subjects: 67
Study 32468672 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan 97/103 mg bid
Number of subjects: 600
Study 32468672 — intervention group
Group type: COMPARATOR
Intervention: enalapril 10 mg bid
Number of subjects: 600
Study 35134798 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser acupuncture
Number of subjects: 99
Study 35134798 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser acupuncture
Number of subjects: 99
Study 34695090 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-norm-based intervention (letter mailed to GPs with prescribing data comparison)
Number of subjects: 1214
Study 34695090 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1214
Study 32859392 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-bonded polytetrafluoroethylene
Number of subjects: 105
Study 32859392 — intervention group
Group type: COMPARATOR
Intervention: Standard polytetrafluoroethylene
Number of subjects: 105
Study 34495337 — intervention group
Group type: COMPARATOR
Intervention: Screening before lockdown (November 11, 2019, to March 9, 2020)
Number of subjects: 80
Study 34495337 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening after lockdown (May 14 to September 3, 2020)
Number of subjects: 80
Study 34495337 — intervention group
Group type: EXPERIMENTAL
Intervention: High ctDNA concentration (after lockdown)
Number of subjects: 80
Study 20073016717 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-glucuronidase (BG) treatment
Number of subjects: 125
Study 20073016717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 35602349 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin combined with lifestyle intervention
Number of subjects: 80
Study 35602349 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention
Number of subjects: 80
Study 34024294 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively-Based Compassion Training (CBCT®)
Number of subjects: 56
Study 34024294 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 56
Study 33783339 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program for PEP prescription guidelines
Number of subjects: 20
Study 33783339 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based decision program (CBDP)
Number of subjects: 20
Study 33581954 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable platelet‐rich fibrin (İ‐PRF) in addition to arthrocentesis
Number of subjects: 36
Study 33581954 — intervention group
Group type: COMPARATOR
Intervention: Arthrocentesis alone (Control)
Number of subjects: 36
Study 35927740 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized adherence enhancement (CAE) delivered via telehealth communications, comprising up to four standard treatment modules: Psychoeducation, Communication with Providers, Medication Routines, and Modified Motivational Interviewing.
Number of subjects: 0
Study 35927740 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized adherence enhancement (CAE)
Number of subjects: 0
Study 32066104 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive finger tapping in Alzheimer's patients
Number of subjects: 20
Study 32066104 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-latency afferent inhibition assessment in Alzheimer's patients
Number of subjects: 20
Study 32066104 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal Assessment Battery scores in Alzheimer's patients
Number of subjects: 20
Study 32066104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical cholinergic deficit in Alzheimer's patients
Number of subjects: 20
Study 35191790 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Touch Chakra Connection
Number of subjects: 0
Study 35191790 — intervention group
Group type: COMPARATOR
Intervention: Healing Touch Video
Number of subjects: 0
Study 33010046 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetically guided dosing of pazopanib
Number of subjects: 25
Study 33010046 — intervention group
Group type: COMPARATOR
Intervention: Historical controls (12 patients not receiving TDM)
Number of subjects: 25
Study 32898024 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100
Study 32898024 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 100
Study 34617261 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 20 mg/kg (first dose), 10 mg/kg (second dose if undergoing therapeutic hypothermia)
Number of subjects: 46
Study 34617261 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol and oxypurinol
Number of subjects: 46
Study 34617261 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxypurinol
Number of subjects: 46
Study 32131074 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions based on the Extended Theory of Planned Behavior (ETPB) including pre-operative patient education, goal setting, and feedback from the day before surgery to 12 months after lung resection
Number of subjects: 87
Study 32131074 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions based on the Extended Theory of Planned Behavior (ETPB)
Number of subjects: 87
Study 32131074 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 87
Study 35817197 — intervention group
Group type: EXPERIMENTAL
Intervention: Active inhibitory transcranial direct current stimulation (tDCS)
Number of subjects: 16
Study 35817197 — intervention group
Group type: COMPARATOR
Intervention: Placebo cathodal stimulation
Number of subjects: 16
Study 34304604 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-clopidogrel
Number of subjects: 37087
Study 34304604 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 37087
Study 34304604 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-dipyridamole
Number of subjects: 37087
Study 34304604 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 37087
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV screening
Number of subjects: 306
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: Full vaccination against HBV
Number of subjects: 306
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 306
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: Public healthcare facility
Number of subjects: 306
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief that HBV vaccine was safe
Number of subjects: 306
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: Ever been screened for HBV
Number of subjects: 306
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-perceived risk of HBV infection
Number of subjects: 306
Study 32645078 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare facility with infection control guidelines
Number of subjects: 306
Study 34209422 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusarium proliferatum strains
Number of subjects: 63
Study 34209422 — intervention group
Group type: EXPERIMENTAL
Intervention: F. brachygibbosum strains
Number of subjects: 63
Study 34209422 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusarium caatingaense, F. clavum, F. incarnatum
Number of subjects: 63
Study 34209422 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusarium solani strains
Number of subjects: 63
Study 32127214 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy
Number of subjects: 0
Study 32127214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34379121 — intervention group
Group type: COMPARATOR
Intervention: 5% fluoride
Number of subjects: 120
Study 34379121 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% xylitol
Number of subjects: 120
Study 34379121 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% xylitol
Number of subjects: 120
Study 34379121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 36255730 — intervention group
Group type: EXPERIMENTAL
Intervention: Gram stain-guided initial antibiotic therapy
Number of subjects: 0
Study 36255730 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based group
Number of subjects: 0
Study 34107720 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined supplementation with vitamin D (40,000 IU) and omega-3 fatty acids (8,000 mg) twice a day for 6 weeks
Number of subjects: 150
Study 34107720 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 150
Study 33048667 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial near-infrared photobiomodulation (tNIR-PBM)
Number of subjects: 14
Study 33048667 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 14
Study 33169443 — intervention group
Group type: COMPARATOR
Intervention: Control group saw existing industry-standard labels
Number of subjects: 7516
Study 33169443 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictograph container design
Number of subjects: 7516
Study 33169443 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictograph serving design
Number of subjects: 7516
Study 33169443 — intervention group
Group type: EXPERIMENTAL
Intervention: Pie-chart serving design
Number of subjects: 7516
Study 33169443 — intervention group
Group type: EXPERIMENTAL
Intervention: Food label serving design
Number of subjects: 7516
Study 32229541 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary tele-rehabilitation (PTR) for 10 weeks (60 min, three times weekly)
Number of subjects: 134
Study 32229541 — intervention group
Group type: COMPARATOR
Intervention: Conventional pulmonary rehabilitation (PR) for 10 weeks (90 min, two times weekly)
Number of subjects: 134
Study 34978887 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepotidacin 1,500‐mg oral dose twice daily for 5 days
Number of subjects: 0
Study 34978887 — intervention group
Group type: COMPARATOR
Intervention: Active comparator (not specified)
Number of subjects: 0
Study 33260235 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical anticoagulation service (CS)
Number of subjects: 30
Study 33260235 — intervention group
Group type: COMPARATOR
Intervention: Regular medical care (RMC)
Number of subjects: 30
Study 34892649 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐Pong (proprioceptive training group)
Number of subjects: 15
Study 34892649 — intervention group
Group type: COMPARATOR
Intervention: Control group (video‐only version of Pong)
Number of subjects: 15
Study 36328325 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Satisfaction (LS)
Number of subjects: 1259
Study 36328325 — intervention group
Group type: EXPERIMENTAL
Intervention: Day Affect (DA)
Number of subjects: 1259
Study 36328325 — intervention group
Group type: COMPARATOR
Intervention: Control group (functional description of health states)
Number of subjects: 1259
Study 33226332 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 37.5 mg, 75 mg, 150 mg, or 300 mg
Number of subjects: 690
Study 33226332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690
Study 36427815 — intervention group
Group type: EXPERIMENTAL
Intervention: Active LF‐rTMS
Number of subjects: 19
Study 36427815 — intervention group
Group type: COMPARATOR
Intervention: Sham LF‐rTMS
Number of subjects: 19
Study 33369253 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg heat therapy (HT)
Number of subjects: 16
Study 33369253 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (C)
Number of subjects: 16
Study 32955455 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health (mHealth): entertaining educational audio capsules and voice immunization reminders via mobile phone
Number of subjects: 387
Study 32955455 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face: community mobilization activities, including 3 small group meetings
Number of subjects: 387
Study 32955455 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth strategy
Number of subjects: 387
Study 32955455 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 387
Study 32955455 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual services)
Number of subjects: 387
Study 32290787 — intervention group
Group type: EXPERIMENTAL
Intervention: TMD + Nuts
Number of subjects: 34
Study 32290787 — intervention group
Group type: EXPERIMENTAL
Intervention: TMD + VOO
Number of subjects: 34
Study 32290787 — intervention group
Group type: COMPARATOR
Intervention: Control diet (low-fat diet recommendations)
Number of subjects: 34
Study 33741520 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 70
Study 33741520 — intervention group
Group type: COMPARATOR
Intervention: Non-yoga group
Number of subjects: 70
Study 36066319 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (RBCs transfused when hemoglobin <7.5 g/dl)
Number of subjects: 617
Study 36066319 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfusion triggers: <9.5 g/L intraoperatively, <9.5 g/L in intensive care, <8.5 g/dl on the ward)
Number of subjects: 617
Study 36066319 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 617
Study 36066319 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 617
Study 33826087 — intervention group
Group type: EXPERIMENTAL
Intervention: Tell‐Show‐Do Technique (TSD‐T)
Number of subjects: 52
Study 33826087 — intervention group
Group type: COMPARATOR
Intervention: Hiding Dental‐Needle Technique (HDN‐T)
Number of subjects: 52
Study 34418670 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES + exercise therapy
Number of subjects: 50
Study 34418670 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 50
Study 32049561 — intervention group
Group type: EXPERIMENTAL
Intervention: Submandibular gland duct graft
Number of subjects: 28
Study 32049561 — intervention group
Group type: COMPARATOR
Intervention: Vein graft
Number of subjects: 28
Study 33651730 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat SIT training (n = 9)
Number of subjects: 18
Study 33651730 — intervention group
Group type: EXPERIMENTAL
Intervention: Uphill SIT training (6% gradient, n = 9)
Number of subjects: 18